Author | Lightnews

ONJ Cancer Research Institute @onjcri.org.au · 1d

ONJCRI joins AAMRI in calling on the Federal Government to release the full MRFF in the 26–27 Federal Budget.

The MRFF was created to deliver $1 billion every year for lifesaving research, but currently, only about $650 million is being released.

Visit aamri.org.au/mrff/

#releasethefullMRFF

Reposted by ONJ Cancer Research Institute

Prof Eliza Hawkes @elizahawkes.bsky.social · 5d

Our fantastic @onjcri.org.au and @lardr.bsky.social teams presenting lymphoma research orals at #HSANZ Blood conference in Perth. Dr Liz Goodall, Dr Allison barraclough, Eliza Chung and Rebecca nightingale and Dr Arina Martynchyk. All rising @womeninlymphoma.bsky.social

1 2

ONJ Cancer Research Institute @onjcri.org.au · 6d

Thank you Shane for having Dr Ju and Dr Parathan on Sunday's show, it was a pleasure to share more about our research with RRR's listeners.

1

ONJ Cancer Research Institute @onjcri.org.au · 6d

@agitg.bsky.social

ONJ Cancer Research Institute @onjcri.org.au · 6d

New trial sites have been activated for the advanced #cholangiocarcinoma BIL-PPP phase II study in VIC, NSW, QLD and SA, making it accessible to more Australians.

➡️ Learn more: https://ow.ly/xqo650XjsBM

The BIL-PPP trial is funded by the Wayne Elphinstone Memorial Fund, AstraZeneca and AGITG

1

ONJ Cancer Research Institute @onjcri.org.au · 9d

Catch ONJCRI’s Dr Pavitha Parathan and Dr @davidyiju.bsky.social on @drshanerrr.bsky.social’s RRR program, Einstein A Go-Go this morning 📻
Talking bowel cancer and novel cancer treatment delivery systems 🔬

#sciencemedia #cancerresearch

1 1 2

ONJ Cancer Research Institute @onjcri.org.au · 11d

ONJCRI researchers have linked two nervous system components to bowel cancer growth, creating promising new avenues for treatment with existing approved migraine therapies.

The findings were published in The BMJ Oncology today.

➡️ https://ow.ly/PCFE50XfWVh

#BowelCancer #Neuropeptides #ONJCRI

ONJ Cancer Research Institute @onjcri.org.au · 12d

We are thrilled to be partners with the @cccolab.bsky.social and are looking forward to working together to improve outcomes for children with cancer.

Children's Cancer CoLab @cccolab.bsky.social · 12d

We welcome Olivia Newton-John Cancer Research Institute as Children's Cancer CoLab’s 9th research partner:
www.cccolab.org.au/news-stories...
@onjcri.org.au @hudsonresearch.bsky.social @petermaccc.bsky.social @wehi-research.bsky.social @monashuniversity.bsky.social
#ChildhoodCancer #Leukaemia

1 1

ONJ Cancer Research Institute @onjcri.org.au · 19d

This National Carers Week, we celebrate the significant role of carers in the lives of people with cancer by sharing the powerful story of one of ONJCRI’s valued supporters.

➡️ Read Gary's story: https://ow.ly/JZQV50XaRtu

1 1

ONJ Cancer Research Institute @onjcri.org.au · Sep 25

ONJCRI researchers and collaborators at @unimelb.bsky.social and RMIT have developed a novel nanomedicine delivery system with highly ordered structures that enhance cargo delivery to their targets.

➡️ Read the paper: ow.ly/XmYX50X1j4I

#LipidNanoparticles #Nanomedicine #CancerResearch

1 3

ONJ Cancer Research Institute @onjcri.org.au · Sep 24

Today, we celebrate World Cancer Research Day, a recognition of the vital role of research in improving cancer outcomes and reducing the global cancer burden.

➡️ Learn more about our research: www.onjcri.org.au/ou...

#WorldCancerResearchDay

2

Reposted by ONJ Cancer Research Institute

NDLR_conference @ndlrconference.bsky.social · Sep 12

We are thrilled to announce Prof @elizahawkes.bsky.social Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.

2 6

ONJ Cancer Research Institute @onjcri.org.au · Sep 8

Researchers at ONJCRI, the University of Washington and @wehi-research.bsky.social have created novel "designer proteins" that can both activate and block cell death as required under different conditions.

➡️ Read the Science Advances paper: ow.ly/5glk50WSRnT

#CellDeath #Apoptosis #ONJCRI

1

ONJ Cancer Research Institute @onjcri.org.au · Aug 22

Researchers at ONJCRI, @wehi-research.bsky.social and @petermaccc.bsky.social have discovered that a known protein complex can stop a common type of blood cancer in its tracks.

The findings were published in @natcomms.nature.com

➡️ Read more: ow.ly/Ca4S50WHVrA

#Lymphoma #CRISPR

4

ONJ Cancer Research Institute @onjcri.org.au · Aug 5

📚 Congratulations to Dr Sarah Yeo, lead author of TRACKER Biobank's first peer-reviewed publication, which explores the challenges and future directions for lung cancer biobanking in Australia.

Read the review here: ow.ly/jlvA50Wze5Y

#LungCancerResearch #CancerResearch #Biobank #ONJCRI

1

Reposted by ONJ Cancer Research Institute

TOGA @togaanz.bsky.social · Jul 31

Today, we stand with patients, families, clinicians, and researchers to raise awareness of lung cancer.

- 36 Australians are diagnosed with lung cancer each day
- Lung cancer claims the most lives of any cancer in Australia
- Less than 6% of cancer research funding is allocated to thoracic cancers

1 1 4

Reposted by ONJ Cancer Research Institute

The Medical Journal of Australia @mja.com.au · Jul 27

Bowel cancer rates are rising in young people, and researchers are working tirelessly to find out why, writes Dr Lisa Mielke

buff.ly/SpTGiBQ

@onjcri.org.au @lisa-mielke.bsky.social

2 3

ONJ Cancer Research Institute @onjcri.org.au · Jul 27

🎗️ This World Head and Neck Cancer Day, we're highlighting ONJCRI's START-HN trial: a game-changing combination of precision radiotherapy and revolutionary immune monitoring techniques that can track how immune cells respond to treatment.

Read more here: ow.ly/el1V50WvBBy

ONJ Cancer Research Institute @onjcri.org.au · Jul 23

We are thrilled to share that the ACRF Centre for Precision Medicine has officially opened at ONJCRI.

Thank you to ACRF for making this new facility become a reality.

➡️ Read more about our new Centre: ow.ly/mcJl50WtK57

#ACRF #CancerResearch #PrecisionMedicine #ONJCRI

1 2

ONJ Cancer Research Institute @onjcri.org.au · Jul 17

💡 Breakthrough in rare cancer care

Research led by Prof Eliza Hawkes shows that 3D imaging can revolutionise how we monitor treatment for primary central nervous system lymphoma (PCNSL), a rare but aggressive cancer.

Read the full study here: ow.ly/Nler50WqYMI

ONJ Cancer Research Institute @onjcri.org.au · Jul 16

🧠 This Glioblastoma (GBM) Awareness Day, we highlight The Centre for Research Excellence in Brain Cancer's Biomarkers in Brain project.

"This valuable resource will allow us to push forward with research to find better treatments for GBM patients.”

➡️ Learn more: ow.ly/NFAm50Wqiel

ONJ Cancer Research Institute @onjcri.org.au · Jul 11

Congratulations to Dr Lisa Mielke, who received a prestigious Australian Research Council (ARC) Future Fellowship totalling $1.13 million to research new molecules for future drug and vaccine development.

➡️ Learn more: ow.ly/GSAP50Wo6L1

#FutureFellowship #ONJCRI

Dr Lisa Mielke awarded ARC Future Fellowship

This ARC Future Fellowship will allow Dr Mielke and her team to research new molecules for future drug and vaccine development.

ow.ly

8

ONJ Cancer Research Institute @onjcri.org.au · Jul 11

🎯 Game-changer for lymphoma treatment

ONJCRI researchers have cracked the code on predicting which blood cancer patients will respond best to a powerful combo of radiotherapy and immunotherapy. In @bloodjournals.hematology.org

Read more on our website: ow.ly/CnZc50Wo6gw

#Cancer #Lymphoma

1 1

ONJ Cancer Research Institute @onjcri.org.au · Jul 10

The first publication from our rare cancers clinical trial (MoST CIRCUIT) was published in‪ @jamaoncology.com‬. Congratulations to A/Prof Oliver Klein and team!

Read more: ow.ly/gr8O50Wnnxv

Thank you to @bms-news.bsky.social, Omico, and the Minderoo Foundation.

Rare cancers clinical trial findings published in JAMA Oncology

This is the first publication on a patient cohort treated as part of the MoST CIRCUIT rare cancers clinical trial, sponsored by ONJCRI.

ow.ly

1

ONJ Cancer Research Institute @onjcri.org.au · Jul 10

Congratulations to ‪@davidyiju.bsky.social‬ who has received funding through TIA’s Pipeline Accelerator program.

The funding will allow Dr Ju, Dr Shiyao Li and Prof Marco Herold to work with the BASE mRNA facility to pursue research on mRNA-based immunotherapies.

➡️ ow.ly/30yH50Wm72I

TIA Accelerator Program funding for research on mRNA immunotherapies

This funding will allow the team to collaborate with the BASE mRNA facility and advance their research into mRNA-based immunotherapies.

ow.ly

1